Literature DB >> 11745338

The p38 mitogen-activated protein kinases can have opposing roles in the antigen-dependent or endotoxin-stimulated production of IL-12 and IFN-gamma.

R A Salmon1, X Guo, H S Teh, J W Schrader.   

Abstract

The p38 mitogen-activated protein kinases (p38 MAPK) are activated in lymphocytes and acessory cells during innate and antigen-specific responses. We show that an inhibitor of two isoforms of p38 MAPK, SB 203580, inhibited the antigen-initiated production of IL-12, and IFN-gamma by cultures of splenic APC and naive CD4(+) T cells. Paradoxically, SB 203580 enhanced the LPS plus IFN-gamma-initiated production of IL-12 by peritoneal exudate macrophages, and the LPS-initiated of the production of both IL-12 and IFN-gamma by non-T non-B (scid) splenocytes. The enhancing effect of SB 203580 on the production of IL-12 by peritoneal exudate macrophages stimulated by LPS and IFN-gamma was dose dependent (EC(50) 0.3 microM), was only seen at lower concentrations of IFN-gamma and was due, at least in part, to a dose-dependent (IC(50) 0.3 microM) inhibition of the production of IL-10. These results indicate first, that p38 MAP kinase activity is required for the production of IL-10, as well as that of proinflammatory cytokines such as IL-12 and IFN-gamma, and, second, that the net effects of SB 203580 on the production of IL-12 and IFN-gamma can be positive or negative, depending on stimuli, cell populations, and levels of cytokines such as IFN-gamma and IL-10.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11745338     DOI: 10.1002/1521-4141(200111)31:11<3218::aid-immu3218>3.0.co;2-9

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

Review 1.  Mechanisms of immune resolution.

Authors:  Alfred Ayala; Chun-Shiang Chung; Patricia S Grutkoski; Grace Y Song
Journal:  Crit Care Med       Date:  2003-08       Impact factor: 7.598

2.  PATHOLOGICAL ASPECTS OF THE ANTI-INFLAMMATORY/IMMUNE SUPPRESSIVE RESPONSE IN SEPSIS AND SHOCK.

Authors:  Alfred Ayala; Yanli Ding; Rebecca J Rhee; Lesley A Doughty; Patrician S Grutkoski; Chun-Shiang Chung
Journal:  Rec Res Dev Immunol       Date:  2003-01-12

3.  Transcriptional suppression of IL-27 production by Mycobacterium tuberculosis-activated p38 MAPK via inhibition of AP-1 binding.

Authors:  Jidong Zhang; Xuesong Qian; Huan Ning; Christopher S Eickhoff; Daniel F Hoft; Jianguo Liu
Journal:  J Immunol       Date:  2011-04-11       Impact factor: 5.422

4.  Role of innate immune factors in the adjuvant activity of monophosphoryl lipid A.

Authors:  Michael Martin; Suzanne M Michalek; Jannet Katz
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

5.  Role of mitogen-activated protein kinases and NF-kappaB in the regulation of proinflammatory and anti-inflammatory cytokines by Porphyromonas gingivalis hemagglutinin B.

Authors:  Ping Zhang; Michael Martin; Suzanne M Michalek; Jannet Katz
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

6.  Secretory mediators regulate Nod2-induced tolerance in human macrophages.

Authors:  Matija Hedl; Clara Abraham
Journal:  Gastroenterology       Date:  2010-09-18       Impact factor: 22.682

7.  The regulation of Th1 responses by the p38 MAPK.

Authors:  Ziyan Yang; Xia Zhang; Patricia A Darrah; David M Mosser
Journal:  J Immunol       Date:  2010-10-11       Impact factor: 5.422

8.  Vav proteins control MyD88-dependent oxidative burst.

Authors:  Ana V Miletic; Daniel B Graham; Vivianne Montgrain; Keiko Fujikawa; Tracie Kloeppel; Karry Brim; Brian Weaver; Robert Schreiber; Ramnik Xavier; Wojciech Swat
Journal:  Blood       Date:  2006-12-07       Impact factor: 22.113

Review 9.  Leishmania interferes with host cell signaling to devise a survival strategy.

Authors:  Suvercha Bhardwaj; Neetu Srivastava; Raki Sudan; Bhaskar Saha
Journal:  J Biomed Biotechnol       Date:  2010-04-08

10.  Selective activation of the p38 MAPK pathway by synthetic monophosphoryl lipid A.

Authors:  Caglar Cekic; Carolyn R Casella; Chelsea A Eaves; Atsushi Matsuzawa; Hidenori Ichijo; Thomas C Mitchell
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.